Stanley Riddell

Biography
Stanley Riddell is a physicianscientist at the Fred Hutchinson Cancer Center where he has contributed to the development of genemodified cell therapies for cancer.Riddell trained in medical oncology and joined the faculty at the Fred Hutchinson Cancer Center, where he established his research program. Throughout his career, Riddell has been a pioneer in the field of genemodified cell therapies, particularly CART cells. His research has focused on genetically modifying T cells to attack cancer, which has shown remarkable promise in treating leukemia and lymphoma.Riddell has also made significant contributions to the field of stem cell transplantation where he developed innovative strategies to reduce graftversushost disease. Riddell's research has earned him numerous awards and honors. He is a recipient a Research Professor of the American Cancer Society, the International Society for Biological Therapy Team Science Award, and a Hans Fischer Senior Fellow Award at the Technical University of Munich.

---

Talk
Next generation gene modified cell therapies for cancer
Adoptive T cell therapy holds great promise for treating refractory blood cancers. Despite high initial response rates, many patients subsequently relapse. Understanding the mechanisms of relapse has informed the development of next generation approaches that can provide more sensitive, specific, and complete elimination of cancer cells.